In gene level, oncogenic signaling pathways in tumor cells, such as IFN-γ/JAK2/IFN, ALK/STAT3, PI3K, and MEK/ERK/STAT1 can activate PD-L1 expression [72-74]. The gene discussed is JAK2; the disease is neoplasm.